Endotracheal Tubes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Endotracheal Tubes Pipeline Market Report Overview

Endotracheal tubes are used to maintain an unobstructed passageway especially to deliver oxygen or anesthesia to the lungs during surgery or any airway management procedure. The curved tube is placed through the patient’s nose or mouth into the trachea (windpipe).

The endotracheal tubes pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·        United States

·        Europe

·        Canada

·        Singapore

·        United Kingdom

Key Regulatory Paths ·        510(k)

·        CE

·        EUA

·        HSA

·        MDL

Key Companies ·        Allvivo Vascular Inc

·        Avir Medical Pte Ltd

·        Baylor College of Medicine

·        Enox Biopharma Inc (Inactive)

·        Fogless International AB

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Endotracheal Tubes Pipeline Market Segmentation by Territories

A few of the key territories for the endotracheal tube pipeline market are the United States, Europe, Canada, Singapore, and the United Kingdom. As of March 2024, the United States accounted for the highest number of pipeline products.

Endotracheal Tubes Pipeline Market Analysis by Territories, 2024 (%)

Endotracheal Tubes Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Endotracheal Tubes Pipeline Market

Download a Free Report Sample

Endotracheal Tubes Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the endotracheal tubes pipeline products market are 510(k), CE, EUA, HAS, MDL among others. As of March 2024, 510(k) was the most followed pathway for pipeline products in the market.

Endotracheal Tubes Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Endotracheal Tubes Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Endotracheal Tubes Pipeline Market

Download a Free Report Sample

Endotracheal Tubes Pipeline Market – Competitive Landscape

A few of the key companies associated with the endotracheal tubes pipeline market are Allvivo Vascular Inc, Avir Medical Pte Ltd, Baylor College of Medicine, Enox Biopharma Inc (Inactive), Fogless International AB among others.

Allvivo Vascular Inc: It is a medical technology company, which designs and develops biocompatible and antimicrobial coatings for medical devices and combination products. The company offers products that are based on Gatekeeper antimicrobial technology, which supports clients to practice responsible infection control. The company sells its products through a network of distributors across the US.

Baylor College of Medicine.: Baylor College of Medicine (BCM) is a health science university that offers educational services. It provides research, patient care, education, and community services. . The college offers various educational courses including M.D. Programs, Ph.D. programs, doctor of nurse practice, P.A. programs, dual degree programs, genetic counseling programs, orthotics and prosthetic programs.

Endotracheal Tubes Pipeline Market Analysis by Companies, 2024

Endotracheal Tubes Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Endotracheal Tubes Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Endotracheal Tubes Pipeline Market Territories Outlook

  • United States
  • Europe
  • Canada
  • Singapore
  • United Kingdom

Endotracheal Tubes Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • EUA
  • HSA
  • MDL

Scope

This report provides:

  • Extensive coverage of the endotracheal tubes under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of endotracheal tubes and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of endotracheal tubes under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Allvivo Vascular Inc
Avir Medical Pte Ltd
Baylor College of Medicine
Enox Biopharma Inc (Inactive)
Fogless International AB
Iasis Molecular Sciences Inc
Illumitube
Johns Hopkins University
Laval University
Medical Device Investments, Inc.
N8 Medical LLC
P3 Medical Ltd
Resultados y Calidad del Sistema Sanitario Publico de Andalucia
Sharklet Technologies Inc
Sonoma Pharmaceuticals Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Teleflex Inc
The Chinese University of Hong Kong
University of Colorado
University of Illinois at Chicago
University of Michigan
University of Minnesota
University of Pittsburgh
University of Texas at San Antonio
University of Virginia
Virginia Commonwealth University
Vrije University Brussel
WynnVision LLC

Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Endotracheal Tubes Overview 8

3 Products under Development 9

3.1 Endotracheal Tubes – Pipeline Products by Stage of Development 9

3.2 Endotracheal Tubes – Pipeline Products by Segment 10

3.3 Endotracheal Tubes – Pipeline Products by Territory 11

3.4 Endotracheal Tubes – Pipeline Products by Regulatory Path 12

3.5 Endotracheal Tubes – Pipeline Products by Estimated Approval Date 13

3.6 Endotracheal Tubes – Ongoing Clinical Trials 14

4 Endotracheal Tubes – Pipeline Products under Development by Companies 15

4.1 Endotracheal Tubes Companies – Pipeline Products by Stage of Development 15

4.2 Endotracheal Tubes – Pipeline Products by Stage of Development 17

5 Endotracheal Tubes Companies and Product Overview 18

5.1 Allvivo Vascular Inc Company Overview 18

5.1.1 Allvivo Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 Avir Medical Pte Ltd Company Overview 19

5.2.1 Avir Medical Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Baylor College of Medicine Company Overview 20

5.3.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 Enox Biopharma Inc (Inactive) Company Overview 21

5.4.1 Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Fogless International AB Company Overview 22

5.5.1 Fogless International AB Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Iasis Molecular Sciences Inc Company Overview 23

5.6.1 Iasis Molecular Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 Illumitube Company Overview 24

5.7.1 Illumitube Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Johns Hopkins University Company Overview 25

5.8.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 25

5.9 Laval University Company Overview 26

5.9.1 Laval University Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 Medical Device Investments, Inc. Company Overview 27

5.10.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

5.11 N8 Medical LLC Company Overview 28

5.11.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28

5.12 P3 Medical Ltd Company Overview 31

5.12.1 P3 Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.13 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 32

5.13.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 32

5.14 Sharklet Technologies Inc Company Overview 33

5.14.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.15 Sonoma Pharmaceuticals Inc Company Overview 34

5.15.1 Sonoma Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.16 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 35

5.16.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 35

5.17 Teleflex Inc Company Overview 36

5.17.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.18 The Chinese University of Hong Kong Company Overview 37

5.18.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 37

5.19 University of Colorado Company Overview 38

5.19.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 38

5.20 University of Illinois at Chicago Company Overview 39

5.20.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 39

5.21 University of Michigan Company Overview 40

5.21.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 40

5.22 University of Minnesota Company Overview 41

5.22.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 41

5.23 University of Pittsburgh Company Overview 42

5.23.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 42

5.24 University of Texas at San Antonio Company Overview 43

5.24.1 University of Texas at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 43

5.25 University of Virginia Company Overview 44

5.25.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 44

5.26 Virginia Commonwealth University Company Overview 45

5.26.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 45

5.27 Vrije University Brussel Company Overview 46

5.27.1 Vrije University Brussel Pipeline Products & Ongoing Clinical Trials Overview 46

5.28 WynnVision LLC Company Overview 47

5.28.1 WynnVision LLC Pipeline Products & Ongoing Clinical Trials Overview 47

6 Endotracheal Tubes- Recent Developments 48

6.1 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 48

6.2 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information 48

6.3 Nov 17, 2023: Ambu Notice for the Annual General Meeting 48

6.4 Nov 09, 2023: Medtronic Xomed Receives 510(K) Clearance For CONTACT Reinforced EMG Endotracheal Tube 48

6.5 Nov 07, 2023: World’s First Smart Breathing Tube for Mechanically Ventilated Patients Set for Human Trials 49

6.6 Nov 05, 2023: Teleflex Reports Third Quarter Financial Results, Full Year 2023 Outlook 50

6.7 Oct 11, 2023: Ambu Appoints New Chief Financial Officer 50

6.8 Oct 09, 2023: Ambu Announces Preliminary Financial Results For The Fiscal Year 2022/23 51

6.9 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 51

6.10 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 51

6.11 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 51

6.12 Aug 03, 2023: Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook 52

6.13 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 55

6.14 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook 55

6.15 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information 57

6.16 Apr 12, 2023: Medtronic has a layoff in California 57

7 Appendix 58

7.1 Methodology 58

7.2 About GlobalData 61

7.3 Contact Us 61

7.4 Disclaimer 61

Table

Endotracheal Tubes – Pipeline Products by Stage of Development 9

Endotracheal Tubes – Pipeline Products by Segment 10

Endotracheal Tubes – Pipeline Products by Territory 11

Endotracheal Tubes – Pipeline Products by Regulatory Path 12

Endotracheal Tubes – Pipeline Products by Estimated Approval Date 13

Endotracheal Tubes – Ongoing Clinical Trials 14

Endotracheal Tubes Companies – Pipeline Products by Stage of Development 15

Endotracheal Tubes – Pipeline Products by Stage of Development 17

Allvivo Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Antimicrobial Endotracheal Tube – Product Status 18

Antimicrobial Endotracheal Tube – Product Description 18

Avir Medical Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

Endotracheal Tube – Pneumonia – Product Status 19

Endotracheal Tube – Pneumonia – Product Description 19

Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 20

Anti-Infective Endotracheal Tube – Product Status 20

Anti-Infective Endotracheal Tube – Product Description 20

Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21

Endotracheal Tube – Product Status 21

Endotracheal Tube – Product Description 21

Fogless International AB Pipeline Products & Ongoing Clinical Trials Overview 22

Endotracheal Tube – Product Status 22

Endotracheal Tube – Product Description 22

Iasis Molecular Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 23

SupraGuard ETT – Product Status 23

SupraGuard ETT – Product Description 23

Illumitube Pipeline Products & Ongoing Clinical Trials Overview 24

Intubation Tube – Product Status 24

Intubation Tube – Product Description 24

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 25

Spiral Slit Endotracheal Tube – Product Status 25

Spiral Slit Endotracheal Tube – Product Description 25

Laval University Pipeline Products & Ongoing Clinical Trials Overview 26

Right Double Lumen Endotracheal Tube – Product Status 26

Right Double Lumen Endotracheal Tube – Product Description 26

Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

Endotracheal Extubation Safe Tube – Product Status 27

Endotracheal Extubation Safe Tube – Product Description 27

N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28

CeraShield Coated Endotracheal Tube – Product Status 28

CeraShield Coated Endotracheal Tube – Product Description 28

N8 Medical LLC – Ongoing Clinical Trials Overview 29

CeraShield Coated Endotracheal Tube – Ceragenin Coated Endotracheal Tubes for the Eradication of Ventilator Associated Pneumonia – A Prospective, Longitudinal, Cross-over, Interrupted Time, Implementation Study (CEASE VAP Study) 30

P3 Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

iTraXS – Product Status 31

iTraXS – Product Description 31

Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 32

Endotracheal Tube – Product Status 32

Endotracheal Tube – Product Description 32

Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Sharklet Endotracheal Tube – Product Status 33

Sharklet Endotracheal Tube – Product Description 33

Sonoma Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Endotracheal Tube Device – Product Status 34

Endotracheal Tube Device – Product Description 34

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 35

Universal Airway Device – Product Status 35

Universal Airway Device – Product Description 35

Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Anti-Biofilm Endotracheal Tube – Product Status 36

Anti-Biofilm Endotracheal Tube – Product Description 36

The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 37

Endotracheal Tube – Product Status 37

Endotracheal Tube – Product Description 37

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 38

Difficult Airway Tube – Product Status 38

Difficult Airway Tube – Product Description 38

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 39

Endotracheal Tube – Product Status 39

Endotracheal Tube – Product Description 39

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 40

Endotracheal Solution Device – Product Status 40

Endotracheal Solution Device – Product Description 40

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 41

Intubation Tube – Product Status 41

Intubation Tube – Product Description 41

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 42

NextGenET – Product Status 42

NextGenET – Product Description 42

University of Texas at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 43

Breathing Tube – Product Status 43

Breathing Tube – Product Description 43

University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 44

Double-Lumen Endotracheal Tube – Product Status 44

Double-Lumen Endotracheal Tube – Product Description 44

Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 45

Pressure Sensing Endotracheal Tube – Product Status 45

Pressure Sensing Endotracheal Tube – Product Description 45

Vrije University Brussel Pipeline Products & Ongoing Clinical Trials Overview 46

Endotracheal Tube – Product Status 46

Endotracheal Tube – Product Description 46

WynnVision LLC Pipeline Products & Ongoing Clinical Trials Overview 47

Endotracheal Tube – Product Status 47

Endotracheal Tube – Product Description 47

Glossary 60

Figures

Endotracheal Tubes – Pipeline Products by Stage of Development 8

Endotracheal Tubes – Pipeline Products by Segment 9

Endotracheal Tubes – Pipeline Products by Territory 10

Endotracheal Tubes – Pipeline Products by Regulatory Path 11

Endotracheal Tubes – Pipeline Products by Estimated Approval Date 12

Endotracheal Tubes – Ongoing Clinical Trials 13

Frequently asked questions

Endotracheal Tubes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Endotracheal Tubes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Endotracheal Tubes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Endotracheal Tubes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.